Atossa Therapeutics Receives FDA Rare Pediatric Disease Designation for (Z)-Endoxifen for McCune-Albright Syndrome
Go back to Atossa Therapeutics Receives FDA Rare Pediatric Disease Designation for (Z)-Endoxifen for McCune-Albright Syndrome| ATOSSA GNTCS (NASDAQ: ATOS) | Delayed: 1.90 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.90 | 52 Week High | $3.64 | |||
| Open | $1.90 | 52 Week Low | $0.14 | |||
| Day High | $1.90 | P/E | N/A | |||
| Day Low | $1.90 | EPS | $0.00 | |||
| Volume | 454 | |||||
